Wisconsin 2023-2024 Regular Session

Wisconsin Assembly Bill AJR74 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	LRB-2422/1
2	2	JKS:klm
3	3	2023 - 2024 LEGISLATURE
4	4	2023 ASSEMBLY JOINT RESOLUTIO N 74
5	5	September 19, 2023 - Introduced by Representatives SUBECK, ROZAR, C. ANDERSON,
6	6	J. ANDERSON, ANDRACA, BARE, BINSFELD, CABRERA, CLANCY, CONSIDINE,
7	7	DITTRICH, DRAKE, EMERSON, HAYWOOD, JACOBSON, JOERS, S. JOHNSON, MADISON,
8	8	MAGNAFICI, MELOTIK, MOORE OMOKUNDE, MURPHY, MURSAU, O'CONNOR,
9	9	OHNSTAD, ORTIZ-VELEZ, PALMERI, RATCLIFF, SHANKLAND, SINICKI, SNODGRASS,
10	10	STUBBS, VINING and KITCHENS, cosponsored by Senators ROYS, BALLWEG,
11	11	CABRAL-GUEVARA, CARPENTER, HESSELBEIN, L. JOHNSON, LARSON, PFAFF,
12	12	SPREITZER, TAYLOR and WIRCH. Referred to Committee on Rules.
13	13	*AUTHORS SUBJECT TO CHANGE*
14	14	Relating to: designating September 2023 and September 2024 as Ovarian Cancer
15	15	Awareness Month.
16	16	Whereas, ovarian cancer is the deadliest of all gynecologic cancers and is most
17	17	common in postmenopausal women; and
18	18	Whereas, ovarian cancer ranks 17th in rates of new cancer cases among women
19	19	in the United States, but ranks sixth among cancer deaths for women, and is the
20	20	leading cause of death from cancer of the female reproductive system; and
21	21	Whereas, ovarian cancer accounts for 2.1 percent of all new cancer cases for
22	22	women, but 4.6 percent of all cancer deaths among women; and
23	23	Whereas, every woman is at risk for ovarian cancer regardless of age, heritage,
24	24	or medical history, and women with a family history of ovarian cancer and other
25	25	genetic factors are at an even higher risk; and
26	26	Whereas, approximately 230,000 women in the United States are living with
27	27	ovarian cancer; and
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14 - 2 -
42	42	LRB-2422/1
43	43	JKS:klm
44	44	2023 - 2024 Legislature
45	45	Whereas, the incidence of ovarian cancer in Wisconsin is slightly higher than
46	46	the national average; and
47	47	Whereas, only half of women diagnosed with ovarian cancer survive beyond five
48	48	years; and
49	49	Whereas, ovarian cancer may not cause early symptoms, and therefore its
50	50	diagnosis often does not occur until the disease has reached an advanced stage, at
51	51	which point the cancer may spread to other parts of the body; and
52	52	Whereas, the five-year survival rate for Stage 1 ovarian cancer is more than
53	53	90 percent, but the five year-survival rate for late-stage ovarian cancer is below 30
54	54	percent, and only 17 percent of ovarian cancers are diagnosed at Stage 1; and
55	55	Whereas, while a mammogram can detect breast cancer and a pap smear can
56	56	detect cervical cancer, there is no reliable early detection test for ovarian cancer; and
57	57	Whereas, additional ovarian cancer research and clinical trials are urgently
58	58	needed to develop prevention strategies, early detection tools, and better therapies,
59	59	in hopes of eventually finding a cure; and
60	60	Whereas, awareness and education are crucial, and women's lives will be saved
61	61	through public awareness about ovarian cancer and its risk factors, signs, and
62	62	symptoms; now, therefore, be it
63	63	Resolved by the assembly, the senate concurring, That the legislature
64	64	proclaims September 2023 and September 2024 to be Ovarian Cancer Awareness
65	65	Month in Wisconsin.
66	66	(END)
67	67	1
68	68	2
69	69	3
70	70	4
71	71	5
72	72	6
73	73	7
74	74	8
75	75	9
76	76	10
77	77	11
78	78	12
79	79	13
80	80	14
81	81	15
82	82	16
83	83	17
84	84	18
85	85	19
86	86	20
87	87	21
88	88	22